Editorial Board — Medscape Gastroenterology

Chair/Journal Editor

  • Geoffrey Braden, MD
    • Drexel University College of Medicine
      Aria Health Hospital System
      Philadelphia, Pennsylvania
 

Board Members

  • Willis Maddrey, MD
    • University of Texas Southwestern Medical Center
      Dallas, Texas
  • Paul Martin, MD
    • University of Miami
      Miami, Florida
  • Brant Oelschlager, MD
    • University of Washington, Seattle
      University of Washington Medical Center
      Seattle, Washington
  • F. Fred Poordad
    • David Geffen School of Medicine
      Cedars Sinai Medical Center
      Los Angeles, California
  • Douglas Rex, MD
    • Indiana University School of Medicine
      Indiana University Hospital
      Indianapolis, Indiana
  • Nancy S. Reau, MD
    • Center for Liver Disease
      University of Chicago
      Chicago, Illinois
 

Chair/Journal Editor Details

Geoffrey Braden, MD
Geoffrey Braden, MD

Geoffrey L. Braden, MD, Clinical Associate Professor, Drexel University College of Medicine, Bala Cynwyd, Pennsylvania; Chief, Division of Internal Medicine, Aria Hospital System, Philadelphia, Pennsylvania

Geoffrey L. Braden, MD, has disclosed no relevant financial relationships.

[ Back to Top ]
 

Board Member Details

John Baillie, MB, ChB
John Baillie, MB, ChB

Professor of Medicine, Wake Forest University Health Sciences; Director, Hepatobiliary and Pancreatic Disorders Service, North Carolina Baptist Hospital, Winston-Salem, North Carolina

John Baillie, MB, ChB, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Pentax, Cook, Inc.; Amylin Pharmaceuticals Corporation
Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP
Received research grant from: Pentax

[ Back to Top ]
David L. Carr-Locke, MD
David L. Carr-Locke, MD

Professor of Medicine, Albert Einstein College of Medicine, Bronx, New York; Chief, Division of Digestive Diseases, Beth Israel Medical Center, New York, New York

Disclosure: David L. Carr-Locke, MD, has disclosed the following relevant financial relationships:
Received income in an amount equal to or greater than $250 from: US Endoscopy; Telemed; ERBE USA, Inc.; Boston Scientific; Cook Medical

[ Back to Top ]
Stephen Hanauer, MD
Stephen Hanauer, MD

Professor of Medicine and Clinical Pharmacology; Chief, Section of Gastroenterology, Hepatology, and Nutrition, University of Chicago, Chicago, Illinois

Stephen Hanauer, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Abbott Laboratories; Centocor Ortho Biotech Inc.; Elan Pharmaceuticals, Inc.; Millennium Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Prometheus Laboratories Inc.; Salix Pharmaceuticals, Inc.; Shire; Takeda Pharmaceuticals North America, Inc.; UCB Pharma, Inc.; Warner Chilcott
Received research grants from: Abbott Laboratories; Centocor Ortho Biotech, Inc.; Elan Pharmaceuticals, Inc.; Pfizer Inc.; Prometheus Laboratories Inc.; Salix Pharmaceuticals, Inc.; Shire; UCB Pharma, Inc.; Warner Chilcott

[ Back to Top ]
David A. Johnson, MD
David A. Johnson, MD

Professor of Medicine, Chief of Gastroenterology, Eastern Virginia Medical School, Norfolk, Virginia

David A. Johnson, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Takeda Pharmaceuticals North America, Inc.; CRA Medical; Eisai Inc.; Centocor Ortho Biotech, Inc.; XenoPort, Inc.; Novartis Pharmaceuticals Corporation
Served as a speaker or a member of a speakers bureau for: Takeda Pharmaceuticals North America, Inc. Received research grants from: AstraZeneca Pharmaceuticals LP; Takeda Pharmaceuticals North America, Inc.; Centocor Ortho Biotech, Inc.
Received income in an amount equal to or greater than $250 from: Takeda Pharmaceuticals North America, Inc.; CRA Medical; Centocor Ortho Biotech, Inc.; XenoPort, Inc.; Novartis Pharmaceuticals Corporation

[ Back to Top ]
Philip O. Katz, MD
Philip O. Katz, MD

Clinical Professor of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania; Chairman, Division of Gastroenterology, Albert Einstein Medical Center, Philadelphia, Pennsylvania

Philip O. Katz, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: AstraZeneca Pharmaceuticals LP; Eisai Inc.; Intec Pharma; Ironwood Pharmaceuticals, Inc.; Novartis Consumer; Sunovion; Takeda Pharmaceuticals North America, Inc.
Served as a speaker or a member of a speakers bureau for: Takeda Pharmaceuticals North America, Inc.

[ Back to Top ]
Brian E. Lacy, MD, PhD
Brian E. Lacy, MD, PhD

Associate Professor of Medicine, Department of Medicine; Director, GI Motility Laboratory, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

Brian E. Lacy, MD, PhD, has disclosed the following relevant financial relationships:
Served as a consultant for: Ferring Pharmaceuticals; Ironwood Pharmaceuticals, Inc.;
Served as a speaker or member of a speakers bureau for: Takeda Pharmaceuticals North America, Inc.; Prometheus Laboratories, Inc.
Received research grant from: Takeda Pharmaceuticals North America, Inc.; The National Institutes of Health (NIH)
Received income in an amount equal to or greater than $250 from: Takeda Pharmaceuticals North America, Inc.; Prometheus Laboratories, Inc.; Ironwood Pharmaceuticals, Inc.; Ferring Pharmaceuticals

[ Back to Top ]
Bret Lashner, MD
Bret Lashner, MD

Professor of Medicine, Cleveland Clinic, Cleveland, Ohio

Bret Lashner, MD, has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Prometheus Laboratories Inc.; Salix Pharmaceuticals, Inc.; Shire; UCB Pharma, Inc.; Abbott Laboratories; Warner Chilcott

[ Back to Top ]
Willis Maddrey, MD
Willis Maddrey, MD

Professor of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas

Willis Maddrey, MD, has disclosed the following relevant financial relationships:
Consults on hepatotoxicity issues for: Bristol-Myers Squibb Company; Merck & Co., Inc.; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Isis Pharmaceuticals, Inc.; Pfizer Inc.; sanofi-aventis; Novartis Pharmaceuticals Corporation; Actelion Pharmaceuticals, Ltd.; Astellas Pharma, Inc.; Vertex Pharmaceuticals Incorporated

[ Back to Top ]
Paul Martin, MD
Paul Martin, MD

Professor of Medicine; Chief, Division of Hepatology, University of Miami School of Medicine and Hospital, Miami, Florida

Paul Martin, MD, has disclosed the following relevant financial relationships:
Served as director, officer, partner, employee, advisor, consultant, or trustee for: Bristol-Myers Squibb Company; Salix Pharmaceuticals, Inc.; Genentech, Inc.; Merck & Co., Inc.
Served as a speaker or a member of a speakers bureau for: Bristol-Myers Squibb Company
Received research grants from: Bristol-Myers Squibb Company; Gilead Sciences, Inc.; Genentech, Inc.

[ Back to Top ]
Brant Oelschlager, MD
Brant Oelschlager, MD

Professor; Director, Center for Videoendoscopic Surgery; Director, Center for Esophageal and Gastric Surgery, Department of Surgery, University of Washington, Seattle, Washington

Brant Oelschlager, MD, has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: EndoGastric Solutions
Received research grants from: Covidien; WL Gore; Cook Biotech; Synovis; Takeda Pharmaceuticals North America, Inc.; Torax Medical

[ Back to Top ]
F. Fred Poordad, MD
F. Fred Poordad, MD

Associate Professor of Medicine, David Geffen School of Medicine; Chief of Hepatology, Cedars Sinai Medical Center, Los Angeles, California

F. Fred Poordad, MD, has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Salix Pharmaceuticals, Inc.; Vertex Pharmaceuticals Incorporated; Gilead Sciences, Inc.; Genentech, Inc.; Onyx Pharmaceuticals, Inc.
Received research grants from: Salix Pharmaceuticals, Inc.; Vertex Pharmaceuticals Incorporated; Gilead Sciences, Inc.; Genentech, Inc.; Novartis Pharmaceuticals Corporation; Merck & Co., Inc.; Anadys Pharmaceuticals, Inc.

[ Back to Top ]
Douglas Rex, MD
Douglas Rex, MD

Distinguished Professor, Indiana University School of Medicine; Director of Endoscopy, Indiana University Hospital, Indianapolis, Indiana

Douglas Rex, MD, has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Olympus Corporation; Braintree Laboratories, Inc.
Received research support from: Given Imaging Ltd.; Olympus Corporation
Served on the scientific advisory boards for: Given Imaging Ltd.; Avantis Medical Systems, Inc.; American BioOptics; Check-Cap Ltd.; Epigenomics AG

[ Back to Top ]
Nancy S. Reau, MD
Nancy S. Reau, MD

Associate Professor of Medicine; Staff Physician, Gastroenterology Section, Center for Liver Disease, University of Chicago, Chicago, Illinois

Nancy S. Reau, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Bristol-Myers Squibb Company; Roche; Gilead Sciences, Inc.; Vertex Pharmaceuticals Incorporated

[ Back to Top ]
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.